| 000 | 01652 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516075655.0 | ||
| 264 | 0 | _c20130329 | |
| 008 | 201303s 0 0 eng d | ||
| 022 | _a1541-2563 | ||
| 024 | 7 |
_a10.3109/15412555.2012.661492 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKerwin, Edward M | |
| 245 | 0 | 0 |
_aEfficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I). _h[electronic resource] |
| 260 |
_bCOPD _cApr 2012 |
||
| 300 |
_a90-101 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntention to Treat Analysis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuscarinic Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aSpirometry |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTropanes _xadministration & dosage |
| 700 | 1 | _aD'Urzo, Anthony D | |
| 700 | 1 | _aGelb, Arthur F | |
| 700 | 1 | _aLakkis, Hassan | |
| 700 | 1 | _aGarcia Gil, Esther | |
| 700 | 1 | _aCaracta, Cynthia F | |
| 773 | 0 |
_tCOPD _gvol. 9 _gno. 2 _gp. 90-101 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/15412555.2012.661492 _zAvailable from publisher's website |
| 999 |
_c21531910 _d21531910 |
||